Intertrade Co.,Ltd. (TYO:3747)
Japan · Delayed Price · Currency is JPY 386.00
-11.00 (-2.77%)
Jul 29, 2026, 3:30 PM JST
Intertrade Financials Overview
Financials in millions JPY. Fiscal year is October - September.
Millions JPY. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 1,842 | 1,836 | 1,849 | 2,011 | 2,056 | 2,157 |
Revenue Growth | 4.01% | -0.70% | -8.06% | -2.19% | -4.68% | -1.73% |
Gross Profit Gross Profit Growth | 556 | 547 | 653 | 734 | 765 | 732 |
Operating Income Operating Income Growth | -25 | -9 | 81 | 200 | 241 | 220 |
Net Income Net Income Growth | 18 | -145 | -97 | 36 | 173 | 201 |
Earnings Per Share EPS Growth | 2.51 | -20.18 | -13.50 | 5.01 | 24.08 | 27.97 |
EPS Growth | - | - | - | -79.19% | -13.93% | 302.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Healthcare Business Healthcare Business Growth | 105.3 | 104.66 | 105.33 | 143.98 | 132.45 | 130.67 |
Business Solution Business Business Solution Business Growth | 251.82 | 258.41 | 298.74 | 257.34 | 277.64 | 267.47 |
Financial Solution Business Financial Solution Business Growth | 1,486 | 1,473 | 1,445 | 1,610 | 1,646 | 1,759 |
Unallocated Adjustment Amount Unallocated Adjustment Amount Growth | -0.17 | -0.01 | -0.04 | -0.05 | -0.07 | -0.08 |
Total Total Growth | 1,843 | 1,836 | 1,849 | 2,011 | 2,056 | 2,157 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 691 | 711 | 1,024 | 994 | 857 | 608 |
Total Debt Total Debt Growth | 208 | 230 | 277 | 197 | 125 | 124 |
Net Cash (Debt) Net Cash Growth | 483 | 481 | 747 | 797 | 732 | 484 |
Net Cash Growth | -14.51% | -35.61% | -6.27% | 8.88% | 51.24% | 60.80% |
Net Cash Per Share Net Cash Per Share Growth | 67.22 | 66.94 | 103.96 | 110.92 | 101.87 | 67.36 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -29 | -12 | 81 | 200 | 270 | 221 |
Capital Expenditures CapEx Growth | - | -3 | -24 | -9 | -1 | -31 |
Free Cash Flow Free Cash Flow Growth | -29 | -15 | 57 | 191 | 269 | 190 |
Free Cash Flow Growth | - | - | -70.16% | -29.00% | 41.58% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 30.18% | 29.79% | 35.32% | 36.50% | 37.21% | 33.94% |
Operating Margin | -1.36% | -0.49% | 4.38% | 9.95% | 11.72% | 10.20% |
Pretax Margin | 1.25% | -8.12% | -4.43% | 3.33% | 10.51% | 11.40% |
Profit Margin | 0.98% | -7.90% | -5.25% | 1.79% | 8.41% | 9.32% |
FCF Margin | -1.57% | -0.82% | 3.08% | 9.50% | 13.08% | 8.81% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 154.09 | - | - | 78.44 | 17.86 | 21.09 |
P/FCF Ratio | - | - | 47.65 | 14.79 | 11.49 | 22.31 |
PS Ratio | 1.51 | 2.56 | 1.47 | 1.40 | 1.50 | 1.97 |